Neurocrine(NBIX) - 2023 Q2 - Earnings Call Transcript
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q2 2023 Earnings Conference Call August 1, 2023 8:00 AM ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO Matt Abernethy - CFO Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development & Strategy Officer Conference Call Participants Paul Matteis - Stifel Tazeen Ahmad - Bank of America Anupam Rama - JPMorgan Phil Nadeau - TD Cowen Jay Olson - Oppenheimer Leon Wang - Barclays Marc Goodman - Leer ...